D2 dopamine receptor gene (DRD2) Taq 1 A polymorphism: Reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele

Pharmacogenetics

Volumn 7, Issue 6, 1997, Pages 479-484

  Thompson, J ^c   Thomas, N ^c   Singleton, A ^c   Piggott, M ^c   Lloyd, S ^c   Perry, E K ^c   Morris, C M ^c   Perry, R H ^a   Ferrier, I N ^b   Court, J A ^c  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c NONE

Author keywords

Corpus striatum; Dopamine D2 receptor; DRD2 Taq1 A polymorphism; Human

Indexed keywords

DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ADULT; AGED; ALLELE; ARTICLE; AUTORADIOGRAPHY; CAUDATE NUCLEUS; CLINICAL ARTICLE; CORPUS STRIATUM; DRUG RECEPTOR BINDING; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; MALE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; SEX DIFFERENCE;

EID: 9844233161     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199712000-00006     Document Type: Article

References (28)

1. Arinami T, Itokawa M, Komiyama T, Mitsushio H, Mori H, Mifune H, Hamaguchi H, Toru M. Association between severity of alcoholism and the A1 allele of the dopamine D2 receptor gene Taq IA RFLP in Japanese. Biol Psych 1993: 33, 108-114.
2. Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997: 6, 577-582.
3. Baldessarini RJ. Dopamine receptors and clinical medicine. In: Neve KA, Neve RL, eds. The dopamine receptors. Totowa, New Jersey: Humana Press, 1997: 457-498.
4. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics 1995: 5, 121-141.
5. Castiglione CM, Deinard AS, Speed WC, Sirugo G, Rosenbaum HC, Zhang Y, Grandy DK, Grigorenko EL, Bonne-Tamir B, Pakstis AJ et al. Evolution of haplotypes at the DRD2 locus. Am J Hum Genet 1995: 57, 1445-1456.
6. Collerton D, Davies C, Thompson P. Lewy body dementia in clinical practice. In: Perry RH, McKeith IG, Perry EK, eds. Dementia with Lewy bodies: clinical, pathological and treatment issues. Cambridge, UK: Cambridge University Press, 1996: 171-186.
7. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 1996: 6, 73-79.
8. Cook CC, Palsson G, Turner A, Holmes D, Brett P, Curtis D, Petursson H, Gurling HM. A genetic linkage study of the D2 dopamine receptor locus in heavy drinking and alcoholism. Br J Psych 1996: 169, 243-248.
9. Cruz C, Camarena B, Mejia JM, Paez, E, Eroza V, Ramon De La Fuente J, Kershenobich D, Nicolini H. The dopamine D2 receptor gene TaqI A1 polymorphism and alcoholism in a Mexican population. Arch Med Res 1995: 26, 421-426.
10. Gelernter J, Goldman D, Risch, N. The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. JAMA 1993: 269, 1673-1677.
11. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 1989: 45, 778-785.
12. Grandy DK, Zhang Y, Civelli, O. PCR detection of the TaqA RFLP at the DRD2 locus. Hum Mol Genet 1993: 2, 2197.
13. Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 1994: 11, 245-256.
14. Hauge XY, Grandy DK, Eubanks JH, Evans GA, Civelli O, Litt M. Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. Genomics 1991: 10, 527-530.
15. Joyce JN, Lexow N, Bird E, Winokur A. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia. Synapse 1988: 2, 546-557.
16. Mayeux R, Denaro J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y. A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol 1992: 49, 492-497.
17. McKeith IG, Fairbairn AF, Perry RH, Thompson P, Perry EK. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Br Med J 1992: 305, 673-678.
18. McKeith IG, Ballard CG, Harrison RWS. Neuroleptic sensitivity to risperidone in Lewy body dementia. Lancet 1995: 346, 699.
19. Mulsant BH, Gershon S. Neuroleptics in the treatment of psychosis in late life: a rational approach. Int J Geriat Psych 1993: 8, 979-992.
20. Nanko S, Ueki A, Hattori M, Dai XY, Sasaki T, Fukuda R, Ikeda K, Kazamatsuri H. No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms. Am J Med Genet 1994: 54, 361-364.
21. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psych 1991: 48, 648-654.
22. Noble EP, Blum K, Khalsa ME, Ritchie T, Montgomery A, Wood RC, Fitch RJ, Ozkaragoz T, Sheridan PJ, Anglin MD et al. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993: 33, 271-285.
23. Noblelc EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ, Brunner RL, Sparkes RS. D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypoth 1994: 42, 257-260.
24. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci 1990: 13, 254-258.
25. Perry RH, Irving D, Blessed G, Fairbairn AF, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990: 95, 119-139.
26. Persico AM, O'Hara BF, Farmer S, Gysin R, Flanagan SD, Uhl GR. Dopamine D2 receptor gene Taq I 'A' locus map including 'A4' variant: relevance for alcoholism and drug abuse. Drug Alc Depend 1993: 31, 229-234.
27. Samuels SC, Katz IR. Neuroleptic medication in elderly people. Curr Opin Psych 1994: 7, 358-363.
28. Uhl G, Blum K, Noble E, Smith S. Substance abuse vulnerability and D2 receptor genes. Trends Neurosci 1993: 16, 83-88.